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Abstract
Background: Polycystic Ovary Syndrome (PCOS) is a common female reproductive disorder with multiple
manifestations. There are relatively few qualitative studies exploring the nature of living with PCOS despite its high
prevalence. Qualitative research can enhance clinical practice via the provision of patient insights into the
experience of living with their condition.
Methods: We conducted two focus groups and three semi-structured interviews of Australian overweight/obese
women with PCOS aged 18–46 years between March and April 2017 who were recruited through social media
advertising. Interviews and focus groups were audio recorded and transcribed verbatim. Thematic analysis was
applied to the data, using the method of constant comparison.
Results: Ten women contributed data from two focus groups and two semi-structured interviews. Five themes
emerged from the data: complexity of the condition with its multiple manifestations, difficulties with delayed
diagnosis and lack of information provided after diagnosis, negative experiences on social media and online forums
and the need for support, frustration over lack of a “cure”; and the impact of symptoms and concern about long-
term sequelae.
Conclusions: Living with PCOS appears to generate a significant degree of anxiety about the future, dissatisfaction
with current treatment models, and loss of feminine identity. Gaps in timely diagnosis, information and support
provision need to be addressed. This includes supporting weight management as a fundamental concern for
women with PCOS.
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Background
Polycystic Ovary Syndrome (PCOS) is a complex hormonal
disorder affecting up to 13% of women [1–4]. The manifes-
tations of PCOS range from reproductive (oligomenor-
rhoea/amenorrhoea and chronic oligo/anovulation with
resultant subfertility), hyperandrogenism (hirsutism, acne,
alopecia), metabolic (dyslipidemia, insulin resistance) and
psychological (mood disorders, body image disorders, and
psychosexual dysfunction). Moreover, PCOS is a disorder
that persists through the lifespan [1]. A meta-analysis has
reported that women with PCOS have an increased preva-
lence of overweight [RR (95% CI): 1.95 (1.52, 2.50)], obesity
[2.77 (1.88, 4.10)] and central obesity [1.73 (1.31, 2.30)]
compared with women without PCOS [5]. Weight gain is a
common presenting complaint [6]. Obesity has a negative
impact on reproductive health [5, 7–9] and is associated
with psychological co-morbidities [5, 10, 11].
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There is some literature about women’s experiences of
living with PCOS, which for many women includes
lengthy delays in diagnosis and followed by inadequate
or no provision of information at diagnosis [12, 13]. Fol-
lowing diagnosis, a range of both positive and negative
reactions have been reported including shock, over-
whelm, and anxiety over long-term risks [14]. Studies
report that quality of life (QoL) is reduced in women
with PCOS [15–20] compared to women without.
Women with PCOS have expressed a number of con-
cerns around fertility including whether they can fall
pregnant, and what pre-conception preparation is
needed [21]. However, there are relatively few qualitative
studies exploring the nature of living with PCOS. Quali-
tative research is proposed to enhance clinical practice
because it “generates a rich description of both local
contexts and individual subjective experiences” [22]. Pa-
tient perspectives and insights into the subjective experi-
ence of living with a chronic condition may complement
findings from quantitative research, highlight gaps in
care, and help inform priorities for future research.
In this paper we report on the experiences of obese/
overweight Australian women living with PCOS drawn
from a qualitative study in order to inform and guide
future patient-centred care for women with PCOS.
Methods
This qualitative study is part of a larger study assessing
the feasibility and acceptability of a method for a rando-
mised controlled trial (RCT) on acupuncture and life-
style for weight management in overweight/obese
women with PCOS [23]. In the process of gathering data
on the outcomes of interest for women, we elicited and
explored women’s experiences of having PCOS. The ob-
jectives of this study were to report on the experiences
of living with PCOS according to women in our study,
in order to highlight gaps in care and inform the
provision of patient-centred healthcare.
Study design
We conducted a mix of both focus groups (two groups
of five women and two women each) and semi-
structured individual telephone interviews (three inter-
views), as not all women were able to attend the planned
focus group sessions. We aimed to conduct focus groups
of 90 min length and interviews of 30 min length. This
study received ethical approval from Western Sydney
University Human Research Ethics Committee (H11935/
28 Nov 2016). All participants provided written in-
formed consent.
Participants
Women living in Sydney, Australia were recruited from
the community through social media sources including
paid advertisements on Facebook and posts on relevant
women’s health organisation pages. We included women
if they self-reported having been diagnosed with PCOS
and self-reported having met the 2003 Rotterdam Cri-
teria [16]; had a body mass index (BMI) > 25 kg/m2 de-
termined from self-reported height and weight; were
aged 18–46 (ie reproductive age); had no other endo-
crine disorders; were not pregnant or had no pregnan-
cies in preceding 6 weeks; were fluent in English; and
were able to attend for a focus group in the Western
Sydney area. Women self-screened using an online ques-
tionnaire delivered using Qualtrics software [24].
We were interested in the views of women who were
trying to conceive as compared with women who were
not, as we hypothesised that the motivations for joining
a clinical trial in these two groups may differ. As such
we used purposive sampling to recruit women to two
focus groups aiming for a sample size of 5–8 partici-
pants per group. We combined the focus group data
with interview data in two groups according to preg-
nancy intention.
Clinical and demographic variables
We collected basic demographic data including age, self-
reported height and weight, ethnicity, educational level,
employment status, and number of children.
Data collection and analysis
An experienced research officer (BB, M.BioStats) facil-
itated the focus groups and two other researchers
(CE, PhD and LI, undergraduate) observed and took
field notes. Focus groups were held on a weekday
evening, in a University setting while interviews were
conducted over the telephone. All researchers are fe-
male. BB has a Health Psychology background, a
broad range of experiences across health sciences but
little prior knowledge of PCOS. CE is a medical doc-
tor (general practitioner/family physician) and acu-
puncture researcher with a strong research interest in
PCOS. LI is an undergraduate Health Promotion stu-
dent with an interest in PCOS. CE and LI had some
experience in qualitative research while BB had exten-
sive experience. LI conducted the telephone inter-
views. The three interviews and two focus groups
explored women’s experiences of living with PCOS,
including motivation to enrol in the study, and clin-
ical outcomes of interest, using a question guide. The
question guide was not pilot tested. There were no
relationships with participants that were established
prior to study commencement. Participants were
aware that CE is a GP and researcher with an interest
in acupuncture for PCOS, and that BB and LI were
research assistants. Women were told that the main
research goal was to assess the feasibility and
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acceptability of a method for a clinical trial on acu-
puncture for weight loss in PCOS. No personal goals
for conducting the research were divulged to partici-
pants and no non-participants were present. Repeat
interviews were not carried out. Focus group discus-
sions and telephone interviews were audio-recorded
and professionally transcribed verbatim. Data was col-
lected until data saturation was reached, which was
determined by discussion between CE, LI and BB.
Transcripts were circulated to participants for check-
ing and no corrections were requested.
We used the method of constant comparison [25] in
thematic analysis of the data [26]. The constant com-
parative method is an inductive data coding process that
enables researchers to derive an understanding of phe-
nomena through the everyday experiences, actions and
words of participants, and provides a systematic method
for organizing, comparing, and understanding similar-
ities and differences between perceptions [27]. A subset
of the transcripts was independently coded by three
members of the research team (BB, CE, FM). Following
this the team members agreed on a set of codes, and
one investigator (BB) conducted a second reading of the
codes and subcodes, and created a final set of emergent
codes. These were then used to compare groups within
the higher order themes. Approximately 20% of tran-
scripts were cross-checked in this manner. We used
Microsoft Excel 2016 version 15.40 to manage data. All
women were given pseudonyms to protect their iden-
tities. None of the investigators were aware of any
potential biases or assumptions about PCOS although
CE was particularly interested in the role of complemen-
tary therapies for weight loss in PCOS. To ensure reli-
ability and validity, we used the strategies of thick
description, triangulation for reliability, peer review
debriefing, developed a coding system, used member
checks, and considered researcher bias [28].
Results
Women were recruited from December 2016 until
March 2017. There were 194 enquiries, of which thirty
women were eligible. Of these, ten contributed qualita-
tive data. The remaining women were uncontactable (9
women), were unable to attend focus groups due to dis-
tance and/or time constraints (8 women), or failed to
attend focus groups and were subsequently uncontact-
able (3 women).
We ran two focus groups of two women and five
women (not trying to conceive and trying to conceive
respectively) in March and April 2017. Three women
could not attend focus groups due to unforeseen cir-
cumstances on the day, and subsequently agreed to be
interviewed. One was not trying to conceive, while the
other two were trying to conceive. Interviews were
conducted in April 2017. Focus groups lasted 104 and
117 min respectively, and the mean duration of tele-
phone interviews was twenty-one minutes (range 17 to
27min).
Of the ten women who contributed qualitative data,
nine women completed the demographic survey, while
one did not return the survey. Women were aged be-
tween 27 and 46 years old (mean age 43.5 years in the
not TTC group and 34 in the TTC group) with a mean
BMI of 36 kg/m2. Five out of ten women were married,
nine worked full time, and six had at least a Bachelor de-
gree qualification. Five women were of European ances-
try, three were of Asian ancestry, and one of Oceanic
ancestry. One woman had four children; the other re-
spondents did not have any children. Five women in the
TTC group reported difficulty in getting pregnant (no
pregnancies despite TTC for 12 months) while the other
two women had been TTC for less than 12 months.
Themes
Five themes emerged on the experience of living with
PCOS: the complexity of the condition; difficulties with
diagnosis; negative online experiences and the need for
support; frustration over lack of a “cure”; and the impact
of symptoms and long-term sequelae. Additional quotes
and sub-themes are provided in Table 1.
(1) “The whole package deal“
A theme that emerged from all women was the complex
nature of PCOS, referred to as the “whole package deal”.
Women were well aware of the multiple manifestations
of PCOS, and spoke of their desire to improve all aspects
of PCOS including weight, menstrual cycles, hirsutism
and acne, and psychological aspects. They felt a lack of
control from the internal and external manifestations of
their condition. Additionally, they knew that they would
have some manifestations of PCOS for the rest of their
life.
"All that packaging that comes with PCOS - hor-
mone imbalance and [unclear], facial hair and all
that other stuff [unclear] whatever is happening in-
side your body because you know something's not
right there - so the whole package deal I guess, be-
cause it does lead to problems " - Keira, TTC
Many women understood that all aspects of PCOS
were linked, and if one aspect improved (such as
weight), others would as well. Georgia said, when asked
about her top priority:
"Probably maintaining a healthy weight, because
with a healthy weight comes regular periods and a
better mental health" - Georgia, not TTC.
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Table 1 Additional quotes
Theme Subtheme Quote
“The whole package deal” Intrinsic, complex
disorder
“There’d be at least one in three women that have it and are dealing with it on a
constant basis. Whether they find that through infertility or weight loss or whatever
else other things. I think the down side of it is that it’s so intrinsic with the rest of
your health. You actually don’t realise it until you’ve got it. Someone says, hey have
a look at this do you know that this affects lots of things. Insulin resistance being
the biggest factor of it. But it’s also intertwined and you don’t realise until you’ve
actually been told” - Annabelle, not TTC
Lack of control “So I think the health benefits of it are that if you can get control of all of it then
you end up with a better life I guess at the end. Because you’re not controlled by
the PCOS and it’s not damaging the rest of the things that go wrong while you
have it” – Annabelle, not TTC
Everything is
linked
“So the weight management and the fertility would be my top things. Because I
think that if I maintained a healthy weight, if I got to a healthy weight and




“So after that I found it’s hard to get pregnant. That’s when the doctor told me
that you know that’s the reason and I took the pill for so long and all of that.
Yeah, I wish someone had told me before” - Harriet, not TTC.
“I know for me until I was diagnosed with PCOS trying to have my third child
I didn’t know I had it at all. So I would have had no clue. But when I look at
what it was and I’ve had irregular periods from the time I was 13 years of age
and heavy periods not just normal periods and that’s what constituted the




“I went to the doctor and the doctor just gave me the tablets, the contraception,
the pill. I was only 16. I’ve had it for years and I’m sick of it. Then I have a lot
of acne. I have a lot. And hair. I got a lot of hair. Thank god for hair lasers.
So all my facial hair is gone but I wasted a lot of money on it. But I hadn’t
been told. I hadn’t been told for a long time. All I had been told was take
the pill” – Annabelle, not TTC
Negative experiences on online forums and




“I generally skip over the positive ones just because I think good luck to them and
all the best but that’s not me. I’m like you, that’s not happening to me so [I don’t
like it]” Keira, TTC
Need for support “The support group. For me that would be something I would probably look
forward to” – Chloe, TTC
Isolation “I would. I don’t know anyone else that has PCOS. Sometimes I’ll talk to my
girlfriends and stuff and they just don’t get it. So it [a support group] would be
good…” - Grace, TTC
No cure No cure “I personally, I find it interesting. With me, I would definitely give it a go. Because of
the fact that I have tried so many other things and they’ve not worked, so I would
100% give it a goal. Other people, I reckon - I would imagine that there is a lot of
other females that have PCOS that have had similar [unclear” – Grace, TTC
Altruism “So I guess having the incentive there to do a trial and a study, and also help the
university out as well, so I guess, yeah, it’s a bit of an incentive to do it...A bit of a
push, and there’s someone relying - not so much relying on me, but you get what I
mean” – Georgia, not TTC
PCOS symptoms and long term sequelae PCOS symptoms “I get a lot of facial hair that I get really self-conscious about” - Grace, TTC
“Now everything is like, I don’t know if it’s too personal or not, but even things such
as hormone levels, sexual desire. All that sort of stuff I think has a lot to do with
PCOS itself because you’re not firing on all eight cylinders like you should be” -
Annabelle, not TTC
“I have pretty irregular periods and pretty emotional too; like I guess just the
mental health [outcomes] as well - I’m very hormonal, so probably look at
that” - Georgia, not TTC
“Yeah, I think that the depression and how you feeling mentally about it they
should because you said we get anxiety and things like that” - Jessica, TTC.
“Because I suffer with depression a lot and I was told that that can sometimes
go hand-in-hand with having the PCOS. So, dealing with the self-esteem side of it,
that would be a big thing for me” - Grace, TTC.
“I think at the moment, my top two priorities would be the healthy weight and
then dealing with the fertility...So the weight management and the fertility would be
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(2) Diagnosis
Some women had experienced lengthy delays before
being officially diagnosed with PCOS.
"I went to the doctor and the doctor just gave me the
tablets, the contraception, the pill. I was only 16. I’ve
had it for years and I'm sick of it. Then I have a lot
of acne. I have a lot. And hair. I got a lot of hair.
Thank god for hair lasers. So, all my facial hair is
gone but I wasted a lot of money on it. But I hadn't
been told. I hadn't been told for a long time. All I
had been told was take the pill" - Harriet, not TTC.
Even after diagnosis, very little information was initially
given on the cause, complications and management of
PCOS.
"I was diagnosed with PCOS 17 years ago and even
then, it wasn’t very well talked about. It wasn’t very
well known. The doctor just basically said, oh you've
got PCOS. I went okay thanks what does that mean
and not much information was given" - Annabelle,
not TTC.
(3) Negative experiences on online forums and social
media, and the need for peer support
Some women, particularly those who were trying to con-
ceive, spoke of negative reactions to positive posts on
online forums and “Facebook” pages, which were usually
about In Vitro Fertilisation (IVF) or fertility in general.
Learning about other women falling pregnant could pro-
voke anxiety or a sense of isolation.
"I think what happens is sometimes - it depends
when I'm - what time it is at night or day. If I go on
and someone's posted something and I go I can re-
late to that, if I click in and see comments I just start
to get anxious and I'm like well why is Clomid work-
ing for me. She only took it three times and now she's
pregnant" - Chloe, TTC
Online forums, despite the negative reactions de-
scribed, could sometimes offer women the ability to
find women who were going through the same
struggles, and whom they could relate to. Women
were generally not getting this support from their
own social group and this could lead to a sense of
isolation.
"Maybe you'll find two or three people who are like
yeah I feel the same." - Keira, TTC.
"I don't know anyone else that has PCOS. Sometimes
I'll talk to my girlfriends and stuff and they just
don't get it. So, it would be good…[to have support
from other women with PCOS]" - Grace, TTC.
(4) “Still now in 2017 we do not have a cure for this”
In the process of contributing data on the feasibility of
the clinical trial, all women spoke of altruistic reasons
for taking part in the study. There was a sense of the
need to find a cure for PCOS. Women in the TTC group
spoke of the frustration they felt at the paucity of accept-
able treatments for PCOS, despite it being such a com-
mon condition.
"This is not a very rare condition or anything. You
would see every other woman nowadays have PCOS.
It just feels bad and something that we're missing
that we do not have a cure for this. Still now in 2017
and we don't have a cure for this, it's like something
so rare. " - Keira, TTC.
Women who were not TTC spoke similarly in terms of
contributing to research and to prevent the younger gen-
erations from suffering in the way that they had. In par-
ticular, Annabelle spoke of her concern for her four
daughters:
"I look at something like this as being it's not just
about me at the end of the day. If it means it helps
somebody else in the study and that’s the main aim
of it is to be able to help other people to not have to
struggle as much. I mean I see that at home with
four girls. But as I said it's so prevalent now if there
is a way to assist anybody to get what they want.
Table 1 Additional quotes (Continued)
Theme Subtheme Quote
my top things. Because I think that if I maintained a healthy weight, if I got to
a healthy weight and maintained it, I think that would help with the self-confidence
and stuff” - Grace, TTC
Chronic disease
risk
“But I think the blood pressure, yeah, the heart and the anxiety is really controlling and
I know, yeah, that’s my problem” – Harriet, not TTC
Psychological
aspects
“Because I suffer with depression a lot and I was told that that can sometimes go
hand-in-hand with having the PCOS. So dealing with the self-esteem side of it, that
would be a big thing for me” - Grace, TTC
PCOS Polycystic Ovary Syndrome, TTC Trying To Conceive
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Whether that’s a baby, a better lifestyle, weight loss"
- Annabelle, not TTC.
(5) PCOS symptoms and long term sequelae
A consistent theme across all participants was the long
struggle they had had with losing weight and the num-
ber of interventions they had tried. Annabelle (not TTC)
had been trying for 27 years; Harriet (not TTC) since
she was a teenager; Jessica (TTC) described “a lifetime of
yoyo dieting”.
"So you change it for a while and you're all good
and then you sort of go back to your normal eating
and your normal pattern. Then you just go up and
down. So you're always doing the up and down
stuff"- Annabelle, not TTC
Some women found the concept of a hormonal imbal-
ance quite distressing, as well as coping with the external
manifestations of hyperandrogenism, and the impact on
libido.
"Hormone balance as well because I was pretty
shocked when my doctor said that you have a high
level of [testosterone]. I was like oh my god I'm turn-
ing into a [man] somehow" - Keira, TTC.
A number of women spoke about battling depression,
anxiety and mental health issues. Low self-esteem from
being overweight and having acne and facial hair were
contributors to poor mental health for some women, as
was anxiety about having a sudden and unexpected
menstrual bleed. There was an understanding of the link
between psychological symptoms and PCOS.
"It can make you more anxious about the situation
you're in. You know back when I did have periods
things of just having the irregularity of them and not
knowing. Hey, they're due round about now and so
preparing yourself to go hey I better put some things
in my handbag. Or I know they're coming so I know
they are going to arrive on this day. Or I'm not going
to bleed through when I stand up" - Annabelle, not
TTC.
Women in both groups were aware of the long-term
sequelae of PCOS, and spoke about their fears of devel-
oping diabetes and heart disease in the future. However,
the women who were not TTC spoke more frequently
about their concerns of impending diabetes. There was a
sense of the continuity of PCOS and how it affected each
life stage from menstruation, fertility, to long term
health. Controlling weight was seen as pivotal as it could
impact on all aspects of PCOS - it could improve
fertility, outward appearances (weight and hyperandro-
genism), self-esteem and mental health, and risk of
chronic disease. It offered women a sense of hope.
Annabelle summarised it as follows:
"So, I think the health benefits of it are that if you
can get control of all of it then you end up with a
better life I guess at the end. Because you're not con-
trolled by the PCOS and it's not damaging the rest
of the things that go wrong while you have it. I don't
think they're exclusive. I think it's a package deal
that if you certainly can control the weight - control
the PCOS that helps to control the weight then
health benefits are just continuous" - Annabelle, not
TTC.
Discussion
This paper reports on the challenging experience of liv-
ing with PCOS. Women in our study struggled with the
complex nature of PCOS, consistent with that found in
other qualitative studies. Crete et al. conducted semi
structured interviews with ten women with PCOS,
reporting four major themes (frustration, confusion,
searching, and gaining control) [29]. In another qualita-
tive study, a major theme was the ongoing struggle to
control symptoms, particularly weight [30]. There were
similar themes of concern for older self, especially with
regard to future infertility; feeling physically inferior;
coming to terms with a chronic condition; shock at the
complex nature of the condition with multiple health
implications in the future [30]. Future research on
women with PCOS should capture the varied aspects of
this disorder, such as mental health outcome measures,
in order to evaluate changes that are meaningful to
women. Clinicians should be aware of the dynamic and
diverse nature of PCOS throughout the reproductive
lifespan and beyond, the impact on women’s quality of
life, and the need to screen for cardiovascular risk fac-
tors and be aware of associated disorders such as ob-
structive sleep apnoea and endometrial cancer. Our
findings support the recommendations in evidence-
based guidelines on PCOS to utilise a multidisciplinary
approach [31].
Women in our study expressed frustration at lengthy
delays in diagnosis, and not being given adequate infor-
mation after diagnosis, consistent with previous research
[13, 32–34]. There are gaps that need to be addressed
with timely diagnosis, providing comprehensive, specific
and practical health information, and adequate training
of health practitioners.
Williams et al. found that women in one study re-
ported that PCOS had affected their feminine identity,
threatening their identity as a woman [35] which was
echoed by women like Keira in our study, who said
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“Oh my god I’m turning into a man somehow”. Simi-
larly, in another qualitative study, some women were
distressed by hirsutism which made them feel “like a
freak” [36]. Quantitative studies have reported that
the physical symptoms of PCOS may cause a loss of
feminine identity, a feeling of being unattractive, and
reduced QoL, although studies in this area are limited
[18, 37]. Physical features of PCOS such as hirsutism
and increased weight appear to impact negatively on
body image and QoL [38, 39] which may then be as-
sociated with depression [40, 41]. Annabelle alluded
to sexual dysfunction and “not firing on all eight cyl-
inders like you should be”. The prevalence of sexual
dysfunction in women with PCOS ranges from 13 to
62% and appears to be greater than in women in the
general population [37]. Therefore, as per the new
international evidence-based guidelines on PCOS, cli-
nicians and health professionals caring for women
with PCOS should be aware of the increased preva-
lence of psychosexual dysfunction, reduced QoL, and
body image distress in this population, particularly if
there are features of hirsutism, overweight/obesity,
and should screen, assess and refer women for sup-
port and treatment as appropriate [31].
Some women in our study reported battling anxiety
and depression, and most of all low self-esteem. Simi-
larly, in the study by Williams et al., participants re-
ported episodes of depression, self-harm and suicidal
ideation [35]. Meta-analyses have consistently reported
increased depression and anxiety scores in women with
PCOS compared to women without PCOS [4, 42–44],
although certainty of the evidence is somewhat limited
by small sample sizes and heterogeneity. Health profes-
sionals who care for women with PCOS should be aware
of the increased prevalence of mental health disorders in
this population, and routinely screen for anxiety and de-
pression in all women at diagnosis [31].
Based on our findings there appears to be a need for
additional support from friends, health practitioners, and
other women with PCOS. This is consistent with themes
emerging from other studies identifying an unmet need
for support from other women with PCOS [30], and
reporting frustration from the lack of support from
healthcare professionals, and active seeking of support
on the internet including from other women with PCOS
[35]. Women in our study were generally unaware of
existing consumer organisations such as the Polycystic
Ovary Syndrome Association of Australia, and voiced a
need for PCOS-specific services. A range of supports ap-
pear to be necessary, such as PCOS-specific online for-
ums, PCOS support groups (such as PCOS Challenge in
the USA, and Verity in the United Kingdom), and access
to educational materials for family members (spouses
and children). Research on support groups as models of
care for women with PCOS is limited, although two
studies report some positive benefits from on-line [45]
and nurse-led support groups [46]. Future research
could explore the role of support groups in the manage-
ment of PCOS.
Last, while women expressed their frustration at many
aspects of living with PCOS, losing weight offered them
hope, a way to improve multiple symptoms and minim-
ise long term sequelae. Yet, all had struggled with “a life-
time of yoyo dieting”. Women with PCOS are more likely
to be obese/overweight than age-matched controls [47],
and weight management is a key goal in PCOS [48]. Ex-
cess weight worsens the features of PCOS [49] while
weight loss improves its features [6]. The women in our
study were aware that their primary goal should be
weight loss, however all had struggled with weight loss
and maintenance. There is a gap between what is known
about the benefits of weight loss in this group, and the
provision of effective, sustainable interventions for
weight loss in PCOS.
This study has some limitations. The major limitation
is that the sample size is small, with a relatively high
dropout rate on the day of the focus group for the
women who were not TTC. Therefore, themes may not
be representative of the views of all women with PCOS
or women with other demographic characteristics or liv-
ing in other geographic locations. Specifically, we could
not capture the experiences of women who could not
speak English, although our sample is culturally diverse,
with 30% of women being of Asian origin. However, we
recruited until saturation was met in the main themes
from the combined interview and focus group data, con-
firming the adequacy of the data that was collected.
We initially chose to conduct focus groups as this
methodology can assist with reaching consensus be-
tween participants who have similar characteristics, and
data is enriched by the interaction between participants
[50]. To overcome pragmatic issues around inability to
attend for face to face focus groups, we offered women
the opportunity to be interviewed over the telephone.
The themes identified across interviews and focus
groups in our study were consistent, indicating that
similar data were collected regardless of the method
used.
Conclusion
To the best of our knowledge this is the first qualitative
study to explore Australian women’s experiences of liv-
ing with PCOS. Consistent with similar qualitative stud-
ies internationally, we report a high level of concern and
frustration amongst Australian women with PCOS
around the complexity of the disorder, the impending
burden of chronic disease, and low self esteem and men-
tal health concerns relating to physical appearance and
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infertility. Living with PCOS appears to generate a sig-
nificant degree of anxiety about the future, dissatisfac-
tion with current treatment models, and loss of feminine
identity. In order to improve the experience of living
with PCOS, gaps in timely diagnosis and information
and support provision need to be addressed. This
includes supporting weight management as a fundamen-
tal concern for women with PCOS.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12905-020-01090-7.
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